Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
NASDAQ:TOI
TOI Stock Chart & Stats
$3.85
-$0.01(-3.73%)
At close: 4:00 PM EST
$3.85
-$0.01(-3.73%)
Day’s Range― - ―
52-Week Range$0.60 - $4.88
Previous CloseN/A
Volume198.36K
Average Volume (3M)1.98M
Market Cap
$234.64M
Enterprise Value$247.13M
Total Cash (Recent Filing)$27.66M
Total Debt (Recent Filing)$27.36M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Mar 05, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding98,381,340
10 Day Avg. Volume2,387,685
30 Day Avg. Volume1,981,250
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)6.46
Price to Sales (P/S)0.06
P/FCF Ratio-0.76
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit3.62
Enterprise Value/Ebitda-5.52
Forecast
1Y Price Target
$6.50Price Target Upside68.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.3
Revenue Forecast (FY)$636.17M
Bulls Say, Bears Say
Bulls Say
Dispensing Revenue AccelerationA substantial year-over-year increase in dispensing revenue indicates improving commercial traction that could drive broader top-line momentum.
Growth OutlookAnalysts cite a durable growth pipeline capable of sustaining twenty percent-plus topline expansion, supporting a stronger outlook for the company's revenue trajectory.
Profitability ExpansionA shift toward value-based care and improving unit economics could enable EBITDA margins to scale to mid-single digits, creating room for a potential valuation rerating as profitability strengthens.
Bears Say
Investor SkepticismMarket discounting of improved visibility and unit economics suggests investor skepticism that may limit upside even if management executes on profitability plans.
Operational Risk — CybersecurityA cybersecurity incident at a key vendor could delay collections and strain short-term cash flow despite reported absence of material volume disruptions.
Share VolatilityA sell-the-news reaction after recent updates has pressured the share price, increasing near-term volatility and downside risk for investors.
Oncology Institute News
TOI FAQ
What was Oncology Institute, Inc.’s price range in the past 12 months?
Oncology Institute, Inc. lowest stock price was $0.60 and its highest was $4.88 in the past 12 months.
What is Oncology Institute, Inc.’s market cap?
Oncology Institute, Inc.’s market cap is $234.64M.
When is Oncology Institute, Inc.’s upcoming earnings report date?
Oncology Institute, Inc.’s upcoming earnings report date is Mar 05, 2026 which is in 18 days.
How were Oncology Institute, Inc.’s earnings last quarter?
Oncology Institute, Inc. released its earnings results on Nov 13, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.113 by -$0.027.
Is Oncology Institute, Inc. overvalued?
According to Wall Street analysts Oncology Institute, Inc.’s price is currently Undervalued.
Does Oncology Institute, Inc. pay dividends?
Oncology Institute, Inc. does not currently pay dividends.
What is Oncology Institute, Inc.’s EPS estimate?
Oncology Institute, Inc.’s EPS estimate is -0.09.
How many shares outstanding does Oncology Institute, Inc. have?
Oncology Institute, Inc. has 98,381,340 shares outstanding.
What happened to Oncology Institute, Inc.’s price movement after its last earnings report?
Oncology Institute, Inc. reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.113. Following the earnings report the stock price went up 28.896%.
Which hedge fund is a major shareholder of Oncology Institute, Inc.?
Currently, no hedge funds are holding shares in TOI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oncology Institute Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.50 (68.83% Upside)
$6.50 (68.83% Upside)
Blogger Sentiment
Bullish
TOI Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 344.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $251.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 10.7%
Last 30 Days ▼ 10.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
162.00%
12-Months-Change
Fundamentals
Return on Equity
-3407.86%
Trailing 12-Months
Asset Growth
-8.69%
Trailing 12-Months
Company Description
Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
TOI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects strong financial performance with significant revenue growth, improvements in adjusted EBITDA, and successful expansion efforts, particularly in Florida. However, challenges such as a cybersecurity incident and a one-time reserve impact were noted. The positives, including increased guidance and strategic advancements, substantially outweigh the negatives.View all TOI earnings summariesTOI Stock 12 Month Forecast
Average Price Target
$6.50
▲(68.83% Upside)
Technical Analysis
Ownership Overview
13.09% Insiders
5.39% Mutual Funds
14.09% Other Institutional Investors
60.57% Public Companies and
Individual Investors